Safety and efficacy of first-line treatment with doxorubicin, cyclophosphamide, bortezomib, dexamethasone and lenalidomide (ACVDL) in newly diagnosed multiple myeloma patients of all ages

Kristian Thidemann Andersen, Maja Hinge, Erik Kay Segel, Tina Ormstrup, Paw Holdgaard, Henrik Boel-Jørgensen, Niels Pallisgaard, Gitte Birk Kerndrup, Torben Plesner

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerPO-112
TidsskriftClinical Lymphoma, Myeloma & Leukemia
Vol/bind15
Udgave nummerSupplement 3
Sider (fra-til)e144
Antal sider1
ISSN2152-2650
DOI
StatusUdgivet - sep. 2015
Begivenhed15th International Myeloma Workshop - Rom, Italien
Varighed: 23. sep. 201526. sep. 2015

Konference

Konference15th International Myeloma Workshop
LandItalien
ByRom
Periode23/09/201526/09/2015

Citationsformater